McChip Resources Inc. Announces Cash Dividend
TORONTO, Feb. 07, 2019 (GLOBE NEWSWIRE) — McChip Resources Inc. (MCS-X) is pleased to announce the declaration of a cash […]
Precision Therapeutics’ Skyline Medical Division Expands Presence in Australia with Three New STREAMWAY Systems at Wangaratta Hospital in Victoria
MINNEAPOLIS, Feb. 07, 2019 (GLOBE NEWSWIRE) — Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision” or “the Company”) today announces its Skyline […]
Cemtrex Discloses 10 New Leading Enterprises Evaluating SmartDesk for Purchase
Long Island City, NY, Feb. 07, 2019 (GLOBE NEWSWIRE) — – Cemtrex Inc. (Nasdaq: CETX, CETXP, CETXW), a leading global technology and manufacturing company, today […]
Innovate Biopharmaceuticals Announces Presentation at BIO CEO & Investor Conference
Presentation will Highlight Progress in Celiac Disease Phase 3 Trial Timeline and NASH RALEIGH, N.C., Feb. 07, 2019 (GLOBE NEWSWIRE) […]
Global Water Resources Sets Fourth Quarter and Full Year 2018 Conference Call for Thursday, March 7, 2019 at 1:00 p.m. ET
PHOENIX, Feb. 07, 2019 (GLOBE NEWSWIRE) — Global Water Resources, Inc. (NASDAQ: GWRS), (TSX: GWR), a pure-play water resource management […]
Relevium Launches the Push and Pull System™, Targeting a New Revenue Stream in the Burgeoning Cosmeceutical Market
MONTREAL, Feb. 07, 2019 (GLOBE NEWSWIRE) — Relevium Technologies Inc. (TSX.V: “RLV”, OTC: “RLLVF” and Frankfurt: “6BX”) (the “Company” or […]
Callitas Health Signs Letter of Intent with NuEthix, LLC to Supply CannaStrip Technology in Nutrition and Fitness Segment
CINCINNATI, OH, Feb. 07, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Callitas Health Inc., (CSE: LILY, OTCQB: MPHMF, FWB: T3F3), […]
CVR Partners to Release Fourth Quarter 2018 Earnings
SUGAR LAND, Texas, Feb. 07, 2019 (GLOBE NEWSWIRE) — CVR Partners, LP (NYSE: UAN), a manufacturer of ammonia and urea […]
CVR Energy to Release Fourth Quarter 2018 Earnings
SUGAR LAND, Texas, Feb. 07, 2019 (GLOBE NEWSWIRE) — CVR Energy, Inc. (NYSE: CVI) plans to release its fourth quarter […]
Fluidigm Announces Participation in Life Science/Pharma and Academic Consortium to Study T Cell-Driven Immune-Mediated Inflammatory Diseases
Gaining insights into inflammatory bowel disease through mass cytometry and Imaging Mass Cytometry analysis of the human mucosal immune system Research aimed […]
